Literature DB >> 11884047

Local recurrence after mesorectal excision for rectal cancer.

A Nesbakken1, K Nygaard, O Westerheim, T Mala, O C Lunde.   

Abstract

AIMS: Controversy still exists about the optimal surgical treatment of rectal cancer. The main purpose of the present study was to compare local recurrence (LR) rates after mesorectal excision (ME) and conventional surgery (CS) technique.
METHODS: All rectal cancer patients from a defined catchment area were included. Outcome after ME in the period 1993-1999 (n=161) was compared with the outcome after CS (n=217) in the period 1983-1992. Partial ME (PME) was the routine in upper, and total ME the routine in mid- and low rectal cancer. The follow-up programmes were identical, and the median observation times very similar (37 and 38 months) in the two periods. Five-year actuarial LR rate and survival were estimated using the Kaplan-Meier method, and adjustment for prognostic factors was performed with Cox regression analysis.
RESULTS: Total LR rate after R0 resection was 7.7% crude and 9% 5 year actuarial in the ME period, as compared with 16.0% crude and 24% actuarial in the CS period (P=0.02). Cox regression analyses confirmed these differences with a hazard ratio of 0.40 for ME vs CS (P=0.02). Isolated LR rate was 2% after ME and 8% after CS. Five-year actuarial total LR rate after rectal resection with curative intent was 11% after ME and 27% after CS (P<0.01). Actuarial total LR rate after PME was 6%, and none of these patients developed isolated LR.
CONCLUSION: Standardization of surgical technique and application of ME resulted in a significant reduction of LRs. LR rate was low after PME, indicating that this procedure is adequate in upper rectal cancer. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2002        PMID: 11884047     DOI: 10.1053/ejso.2001.1231

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  21 in total

1.  Surgery of rectal cancer: still not a science.

Authors:  Federico Bozzetti
Journal:  Int J Colorectal Dis       Date:  2003-10-03       Impact factor: 2.571

Review 2.  Shifting Paradigms in Minimally Invasive Surgery: Applications of Transanal Natural Orifice Transluminal Endoscopic Surgery in Colorectal Surgery.

Authors:  Grace Clara Lee; Patricia Sylla
Journal:  Clin Colon Rectal Surg       Date:  2015-09

3.  Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach.

Authors:  Paal Joranger; Arild Nesbakken; Halfdan Sorbye; Geir Hoff; Arne Oshaug; Eline Aas
Journal:  Eur J Health Econ       Date:  2019-11-09

4.  Prognostic value of serum soluble Fas in patients with locally advanced unresectable rectal cancer receiving concurrent chemoradiotherapy.

Authors:  Qi-lian Liang; Zhou-yu Li; Guo-qiang Chen; Zhen-nan Lai; Bi-rong Wang; Jie Huang
Journal:  J Zhejiang Univ Sci B       Date:  2010-12       Impact factor: 3.066

5.  The oncological safety of laparoscopic total mesorectal excision with sphincter preservation for rectal carcinoma.

Authors:  F Bretagnol; B Lelong; C Laurent; V Moutardier; A Rullier; G Monges; J-R Delpero; E Rullier
Journal:  Surg Endosc       Date:  2005-05-12       Impact factor: 4.584

6.  Local recurrence after laparoscopic resection of T3 rectal cancer without preoperative chemoradiation and a risk group analysis: an Asian collaborative study.

Authors:  Sun-Il Lee; Seon-Hahn Kim; Hwei-Ming Wang; Gyu-Seog Choi; Min-Hua Zheng; Masaki Fukunaga; Jun-Gi Kim; Wai Lun Law; Joe-Bin Chen
Journal:  J Gastrointest Surg       Date:  2007-10-24       Impact factor: 3.452

Review 7.  Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer.

Authors:  Jin-ichi Hida; Kiyotaka Okuno; Tadao Tokoro
Journal:  Surg Today       Date:  2013-12-22       Impact factor: 2.549

8.  [Problems in the treatment of upper rectal carcinoma].

Authors:  T Junginger; P Hermanek
Journal:  Chirurg       Date:  2008-04       Impact factor: 0.955

9.  The pathological assessment of mesorectal excision: implications for further treatment and quality management.

Authors:  P Hermanek; P Hermanek; W Hohenberger; M Klimpfinger; F Köckerling; T Papadopoulos
Journal:  Int J Colorectal Dis       Date:  2003-02-14       Impact factor: 2.571

Review 10.  Patterns of colorectal cancer care in Europe, Australia, and New Zealand.

Authors:  Neetu Chawla; Eboneé N Butler; Jennifer Lund; Joan L Warren; Linda C Harlan; K Robin Yabroff
Journal:  J Natl Cancer Inst Monogr       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.